School of Medicine
Showing 1-10 of 34 Results
Lead Architect, Building for Digital Health, School of Medicine - MDRP'S - Biodesign Program
Current Role at StanfordLead Architect, Building for Digital Health, Stanford Byers Center for Biodesign
Kelly (Sanderson) Ray, NP
Adjunct Clinical Instructor, Educational Programs and Services (EPS)
BioKelly Ray, NP, is board certified as a Family Nurse Practitioner and an Emergency Nurse Practitioner. Kelly completed her nurse practitioner training at Georgetown University, and worked in primary care and corporate health before joining Stanford in 2016. She particularly enjoys helping patients with acute medical needs, and maintains clinical interest in wilderness and travel medicine.
Affiliate, School of Medicine - MDRP'S - Biodesign Program
BioAssistant Director, Biodesign Faculty Fellowship, Stanford Byers Center for Biodesign
Founding Partner, 4i Ventures
President, Kalyan Oaks Advisors
Partha Ray is a healthcare executive, investor and advisor with 20+ years of deal & operating experience at leading global organizations. He has launched 6 FDA-regulated products worldwide and closed venture and strategic transactions which benefit over 9M patients and generate over $20B/yr in revenues today.
Partha works and invests in the intersection DeepTech and MedTech, i.e. robust technology-enabled businesses which aim to deliver proven clinical value. He engages with emerging health companies as expert board member, advisor and/or business executive (e.g. CBO). Partha's academic interests lie in the area of corporate innovation, with a particular focus on leveraging design thinking and interdisciplinary experience sets to enable actual need-based innovation in complex, global organizations. He's Faculty at a post-doc program at Stanford Biodesign and has helped select, mentor and graduate 36 Stanford Faculty to-date.
Global Product & Commercial Experience:
Partha has led global launches of 6 MedTech products and led a $500M/yr commercial business during 9 years in global marketing leadership roles at Medtronic (Diabetes) and Johnson & Johnson (Ethicon). He launched the world's first real-time continuous glucose monitoring (CGM) products, a category that is now serving over 4M users and generating $10B in revenue .
Partha has diverse transactions experience including 8 equity investments, 2 M&As, 5 partnerships, and a JV deal gained over 10+ years in corporate business development, corporate venture capital, private venture capital, and angel investing. He has worked on major MedTech industry deals including a robotics surgery joint venture (Verb Surgical) between J&J (Ethicon) and Alphabet (Verily), the acquisition of Neuwave Medical at J&J (Ethicon), and the structuring of Dexcom Ventures.
Partha hold a BS in Electrical Engineering with honors from Northwestern University, an MBA from the UCLA Anderson School of Management, and was an Innovation Fellow at Stanford Biodesign.